Fizostigmin
|
(IUPAC) ime
|
(3aR,8aS)-1,3a,8-Trimetil-1H,2H,3H,3aH,8H,8aH-pirolo[2,3-b]indol-5-il N-metilkarbamat
|
Klinički podaci
|
Robne marke
|
Antilirium
|
AHFS/Drugs.com
|
Monografija
|
Identifikatori
|
CAS broj
|
57-47-6
|
ATC kod
|
S01EB05 V03AB19
|
PubChem[1][2]
|
5983
|
DrugBank
|
DB00981
|
ChemSpider[3]
|
5763
|
UNII
|
9U1VM840SP Y
|
KEGG[4]
|
D00196 Y
|
ChEBI
|
CHEBI:27953 Y
|
ChEMBL[5]
|
CHEMBL94 Y
|
Hemijski podaci
|
Formula
|
C15H21N3O2
|
Mol. masa
|
275,346 g/mol
|
SMILES
|
eMolekuli & PubHem
|
InChI |
InChI=1S/C15H21N3O2/c1-15-7-8-17(3)13(15)18(4)12-6-5-10(9-11(12)15)20-14(19)16-2/h5-6,9,13H,7-8H2,1-4H3,(H,16,19)/t13-,15+/m1/s1 Y Key: PIJVFDBKTWXHHD-HIFRSBDPSA-N Y |
|
Farmakokinetički podaci
|
Metabolizam
|
Glavni metabolit: Eserolin
|
Farmakoinformacioni podaci
|
Trudnoća
|
C(US)
|
Pravni status
|
℞-only (SAD)
|
Način primene
|
intravenonozno, intramuskularno, ofthalmički
|
Fizostigmin (eserin) je parasimpatomimetski alkaloid. On je reverzibilni inhibitor holinesteraze.
Ova supstanca je sintetisana 1935. Dostupna je pod imenima: Antilirium, Isopto Eserine, Eserin salicilat i Eserin sulfat.
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
- ↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
- ↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit